Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Fine

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|December 1, 1996
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sourcesL Chen, M Pulsipher, D Chen, et al.
Neurologic Clinics|November 1, 1995
High-grade astrocytomasP Y Wen, H A Fine, P M Black, et al.
Neurology|June 1, 1993
Complications of therapy for venous thromboembolic disease in patients with brain tumorsJ M Levin, D Schiff, J S Loeffler, et al.
Journal of Neurovirology|May 19, 1998
Immune parameters affecting adenoviral vector gene therapy in the brainM J Parr, P Y Wen, M Schaub, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1995
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumorsY Manome, P Y Wen, A Hershowitz, et al.
Nature Medicine|May 1, 1996
Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivoY Manome, P Y Wen, Y Dong, et al.
The Pharmacogenomics Journal|December 3, 2014
An in silico screen links gene expression signatures to drug response in glioblastoma stem cellsG Riddick, H Song, S L Holbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomasH A Fine, P Y Wen, M Robertson, et al.
Nature Medicine|October 23, 1997
Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vectorM J Parr, Y Manome, T Tanaka, et al.
Journal of Neurosurgery|July 21, 1999
Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcomeD C Shrieve, E Alexander, P M Black, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|December 1, 1996
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sourcesL Chen, M Pulsipher, D Chen, et al.
Neurologic Clinics|November 1, 1995
High-grade astrocytomasP Y Wen, H A Fine, P M Black, et al.
Neurology|June 1, 1993
Complications of therapy for venous thromboembolic disease in patients with brain tumorsJ M Levin, D Schiff, J S Loeffler, et al.
Journal of Neurovirology|May 19, 1998
Immune parameters affecting adenoviral vector gene therapy in the brainM J Parr, P Y Wen, M Schaub, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1995
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumorsY Manome, P Y Wen, A Hershowitz, et al.
Nature Medicine|May 1, 1996
Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivoY Manome, P Y Wen, Y Dong, et al.
The Pharmacogenomics Journal|December 3, 2014
An in silico screen links gene expression signatures to drug response in glioblastoma stem cellsG Riddick, H Song, S L Holbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomasH A Fine, P Y Wen, M Robertson, et al.
Nature Medicine|October 23, 1997
Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vectorM J Parr, Y Manome, T Tanaka, et al.
Journal of Neurosurgery|July 21, 1999
Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcomeD C Shrieve, E Alexander, P M Black, et al.
Pageof 5